Vpr

Vpr is a protein that is encoded by the Vpr gene in the HIV-1 virus. It is a small, 96 amino acid protein that is involved in the transport of the pre-integration complex (PIC) into the nucleus of the host cell. Vpr also has a role in cell cycle arrest and apoptosis.

Function

Vpr is involved in several stages of the HIV-1 life cycle. It is incorporated into the virus particle during budding and is present in the cytoplasm of the infected cell after fusion of the virus with the cell membrane. Vpr is required for efficient virus replication in non-dividing cells, such as macrophages, because it facilitates the transport of the PIC into the nucleus. This is necessary for the integration of the viral DNA into the host cell genome.

Vpr also induces cell cycle arrest in the G2 phase. This is thought to create a more favorable environment for virus replication. The mechanism by which Vpr induces cell cycle arrest is not fully understood, but it is known to involve the activation of the ATR DNA damage checkpoint.

In addition to its role in virus replication, Vpr has been shown to induce apoptosis in various cell types. This is thought to contribute to the depletion of CD4+ T cells, which is a hallmark of AIDS.

Structure

Vpr is a small protein with a molecular weight of approximately 12 kDa. It is composed of 96 amino acids and has a highly conserved sequence among different HIV-1 isolates. The protein has a flexible N-terminal region and a rigid C-terminal region. The C-terminal region contains three alpha helices, which form a hydrophobic core. The N-terminal region is involved in the interaction with the PIC and the nuclear pore complex.

Clinical significance

Due to its roles in virus replication and cell death, Vpr is a potential target for antiretroviral therapy. Several small molecules that inhibit the function of Vpr have been identified, but none of them have reached clinical trials yet.

Vpr Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.